VXRT
Vaxart, Inc.Company with tickers: VXRT
CIK
72444
CUSIP
92243A200
Shares Outstanding
241,973,011
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $20,876,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $35,811,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $30,744,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-14,935,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-15,591,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.07 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.07 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |